ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "longitudinal studies"

  • Abstract Number: 1220 • ACR Convergence 2021

    Identification of Underlying Disease Domains by Longitudinal Latent Factor Analysis for Secukinumab Treated Patients in Psoriatic Arthritis and Rheumatoid Arthritis Trials

    Xuan Zhu1, Fabian Falck2, Sahra Ghalebikesabi2, Matthias Kormaksson1, Marc Vandemeulebroecke3, Cong Zhang1, Luis Santos4, Chun Hei Kwok4, Dominique West4, Ann-Marie Mallon4, Ruvie Martin1, Aimee Readie1, Kunal Gandhi1, Gregory Ligozio1 and George Nicholson2, 1Novartis Pharmaceuticals Corporation, East Hanover, NJ, 2University of Oxford, Oxford, United Kingdom, 3Novartis Pharma AG, Basel, Switzerland, 4MRC Harwell Institute, Harwell Campus, Oxfordshire, United Kingdom

    Background/Purpose: Secukinumab is a fully monoclonal antibody approved for the treatment of several related autoinflammatory diseases, including psoriasis, psoriatic arthritis (PsA) and ankylosing spondylitis.1 While…
  • Abstract Number: 0159 • ACR Convergence 2021

    Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?

    Xenofon Baraliakos1, Valeria Rios Rodriguez2, Murat Torgutalp2, Anil Dilbaryan2, Hildrun Haibel3, Maryna Verba4, Joachim Sieper3, Jürgen Braun1, Martin Rudwaleit5 and Denis Poddubnyy6, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Charité University Medicine Berlin, Berlin, Germany, 3Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 4Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Berlin, Germany, 5University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany, 6Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: The aim of this study is to investigate the performance of the modified Stokes Ankylosing Spondylitis Scoring System (mSASSS) in assessing spinal radiographic damage…
  • Abstract Number: 1257 • ACR Convergence 2021

    Improvements in Abnormal Laboratory Tests Are Associated with Clinical Outcomes in Patients with Active Systemic Lupus Erythematosus

    Kathryn Connelly1, Rangi Kandane-Rathnayake1, Alberta Hoi2, Worawit Louthrenoo3, Laniyati Hamijoyo4, Jiacai Cho5, Aisha Lateef6, Shue-Fen Luo7, Yeong-Jian Wu8, Zhanguo Li9, Yuan An9, Sandra Navarra10, Leonid Zamora10, Sargunan Sockalingam11, Yanjie Hao12, Zhuoli Zhang12, Yasuhiro Katsumata13, Masayoshi Harigai13, Shereen Oon14, Madelynn Chan15, YI-HSING CHEN16, Sang-Cheol Bae17, Sean O’Neill18, Kathryn Gibson18, Fiona Goldblatt19, Jun Kikuchi20, Tsutomu Takeuchi21, Kristine (Pek Ling) Ng22, Nicola Tugnet23, B.M.D.B. Basnayake24, Yoshiya Tanaka25, C.S. Lau26, Mandana Nikpour27, Vera Golder1 and Eric Morand28, 1Monash University, Clayton, Australia, 2Department of Rheumatology, Monash Health & Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia, 3Maharaj Nakorn Chiangmai, Chiang Mai, Thailand, 4University of Padjadjaran, Bandung, Indonesia, 5National University Health System (NUHS), Singapore, Singapore, 6National University Hospital, Singapore, Singapore, 7Chang Gung Memorial Hospital, Taipei, Taiwan, 8Chang Gung Memorial Hospital, Taoyuan County, Taiwan, 9People's Hospital, Peking University Health Science Center, Beijing, China (People's Republic), 10University of Santo Tomas Hospital, Manila, Philippines, 11University of Malaya, Kuala Lumpur, Malaysia, 12Peking University First Hospital, Beijing, China (People's Republic), 13Tokyo Women's Medical University School of Medicine, Tokyo, Japan, 14Melbourne Health, Parkville, Australia, 15Tan Tock Seng Hospital, Singapore, Singapore, 16Taichung Veterans General Hospital, Taichung, Taiwan (Republic of China), 17Hanyang University Medical Center, Seoul, Republic of Korea, 18Liverpool Hospital, Sydney, Australia, 19Flinders Medical Centre, Adelaide, Australia, 20Keio University School of Medicine, Tokyo, Japan, 21Div. Rheumatology, Keio University, Tokyo, Japan, 22North Shore Hospital, Auckland, New Zealand, 23Auckland District Health Board, Auckland, New Zealand, 24Teaching (General) Hospital, Kandy, Sri Lanka, 25University of Occupational and Environmental Health, Kitakyushu, Japan, 26University of Hong Kong, Hong Kong, Hong Kong, 27University of Melbourne at St Vincent's Hospital, Melbourne, Australia, 28School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre Clayton, Melbourne, Australia

    Background/Purpose: Laboratory tests are routine in the management of SLE. In clinical trial endpoints, data from laboratory tests contribute to responder status, but this is…
  • Abstract Number: 0222 • ACR Convergence 2021

    Effects of Multi-Joint Osteoarthritis Phenotypes on Self-Reported Physical Function over 3.5 Years: The Johnston County Osteoarthritis Project

    Amanda Nelson1, Carolina Alvarez1, Liubov Arbeeva1, Jordan Renner1, Virginia Kraus2, Duncan Lascelles3 and Yvonne Golightly1, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Duke University, Durham, NC, 3North Carolina State University, Raleigh, NC

    Background/Purpose: To determine the differential effects of several literature-based definitions of multi-joint osteoarthritis (MJOA) on change in self-reported physical function in a community-based cohort.Methods: We…
  • Abstract Number: 1259 • ACR Convergence 2021

    Association of SLE Responder Index (SRI) Attainment and Long-term Clinical Outcomes

    Kathryn Connelly1, Rangi Kandane-Rathnayake1, Alberta Hoi2, Worawit Louthrenoo3, Laniyati Hamijoyo4, Jiacai Cho5, Aisha Lateef6, Shue-Fen Luo7, Yeong-Jian Wu8, C.S. Lau9, YI-HSING CHEN10, Sandra Navarra11, Leonid Zamora11, Zhanguo Li12, Yuan An12, Sargunan Sockalingam13, Yanjie Hao14, Zhuoli Zhang14, Madelynn Chan15, Yasuhiro Katsumata16, Masayoshi Harigai16, Shereen Oon17, Sang-Cheol Bae18, Sean O’Neill19, Kathryn Gibson19, Jun Kikuchi20, B.M.D.B. Basnayake21, Tsutomu Takeuchi22, Kristine (Pek Ling) Ng23, Fiona Goldblatt24, Annie Law25, Nicola Tugnet26, Yoshiya Tanaka27, Sunil Kumar28, Michael Tee29, Jin Yu Tan30, Chetan Karyekar31, Mandana Nikpour32, Vera Golder1 and Eric Morand33, 1Monash University, Clayton, Australia, 2Department of Rheumatology, Monash Health & Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia, 3Maharaj Nakorn Chiangmai, Chiang Mai, Thailand, 4University of Padjadjaran, Bandung, Indonesia, 5National University Health System (NUHS), Singapore, Singapore, 6National University Hospital, Singapore, Singapore, 7Chang Gung Memorial Hospital, Taipei, Taiwan, 8Chang Gung Memorial Hospital, Taoyuan County, Taiwan, 9University of Hong Kong, Hong Kong, Hong Kong, 10Taichung Veterans General Hospital, Taichung, Taiwan (Republic of China), 11University of Santo Tomas Hospital, Manila, Philippines, 12People's Hospital, Peking University Health Science Center, Beijing, China (People's Republic), 13University of Malaya, Kuala Lumpur, Malaysia, 14Peking University First Hospital, Beijing, China (People's Republic), 15Tan Tock Seng Hospital, Singapore, Singapore, 16Tokyo Women's Medical University School of Medicine, Tokyo, Japan, 17Melbourne Health, Parkville, Australia, 18Hanyang University Medical Center, Seoul, Republic of Korea, 19Liverpool Hospital, Sydney, Australia, 20Keio University School of Medicine, Tokyo, Japan, 21Teaching (General) Hospital, Kandy, Sri Lanka, 22Div. Rheumatology, Keio University, Tokyo, Japan, 23North Shore Hospital, Auckland, New Zealand, 24Flinders Medical Centre, Adelaide, Australia, 25Singhealth, Singapore, Singapore, 26Auckland District Health Board, Auckland, New Zealand, 27University of Occupational and Environmental Health, Kitakyushu, Japan, 28Counties Manukau Health, Auckland, New Zealand, 29University of the Philippines, Quezon City, Philippines, 30Janssen Asia Pacific, Singapore, Singapore, 31Janssen R&D, Spring House, PA, 32University of Melbourne at St Vincent's Hospital, Melbourne, Australia, 33School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre Clayton, Melbourne, Australia

    Background/Purpose: The SLE Responder Index (SRI) is a composite responder definition employed as a clinical trial endpoint in SLE. Despite its widespread adoption, recent discrepant…
  • Abstract Number: 0245 • ACR Convergence 2021

    Long-term Safety and Effectiveness of Abatacept Treatment in Patients with JIA: 5-year Results from the PRCSG/PRINTO JIA Real-World Registry

    Hermine Brunner1, Daniel Lovell2, Michael Henrickson1, Ruy Carrassco3, Kirsten Minden4, Lyudmila Grebenkina5, James Nocton6, Ingrid Louw7, Linda Wagner-Weiner8, Gabriel Vega Cornejo9, Sylvia Kamphuis10, Vyacheslav Chasnyk11, Heather Walters12, Simone Appenzeller13, Jordi Anton14, Alyssa Dominique15, Robert Wong16, Lixian Dong15, Tzuyung Douglas Kou15, Alberto Martini17 and Nicolino Ruperto18, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, 3Presbyterian Health Services, Albuquerque, NM, 4Charite University Hospital Berlin, Berlin, Germany, 5Togliatti City Clinical Hospital №5, Togliatti, Russia, 6Medical College of Wisconsin, Milwaukee, WI, 7Panorama Medical Centre, Cape Town, South Africa, 8University of Chicago (Comer Children's), Chicago, IL, 9Crea de Guadalajara/Hospital México Americano, Guadalajara, Mexico, 10Sophia Children’s Hospital, Erasmus University Medical Center, Rotterdam, Netherlands, 11Saint-Petersburg State Pediatric Medical Academy, Saint Petersburg, Russia, 12Cohen Children's Hospital, New York, NY, 13Hospital das Clínicas da Universidade Estadual de Campinas, Campinas, Brazil, 14Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain, 15Bristol Myers Squibb, Princeton, NJ, 16Bristol Myers Squibb, Basking Ridge, NJ, 17Paediatric Rheumatology International Trials Organisation (PRINTO), Genoa, Italy, 18IRCCS Istituto Giannina Gaslini; PRINTO, Clinica Pediatrica e Reumatologia, Genova, Italy

    Background/Purpose: Abatacept (ABA) is well tolerated and effective in patients with JIA.1 The Pediatric Rheumatology Collaborative Study Group (PRCSG)/ Paediatric Rheumatology INternational Trials Organisation (PRINTO)…
  • Abstract Number: 1406 • ACR Convergence 2021

    Incidence and General Clinical Features of Giant Cell Arteritis in the ARTESER Multicenter Study

    Jesús T. Sánchez-Costa1, Rafael B. Melero-González2, Elisa Fernández-Fernández3, María T. Silva-Diaz4, Joaquín M. Belzunegui5, Clara Moriano6, Julio Sánchez7, Judit Lluch8, Itziar Calvo9, Vicente Aldasoro10, Lydia Abasolo11, Javier Loricera12, Alberto Ruíz-Román13, Santos Castañeda14, Patricia Moya15, María J. Garcia-Villanueva16, Vanessa A. Navarro-Angeles17, Carles Galisteo18, Anne Riveros-Frutos19, Jose A. Román-Ivorra20, Selene Labrada-Arrabal21, Margarida Vasques-Rocha22, Carlota L. Iñiguez-Ubiaga23, María García-González24, Clara Molina-Almela25, María Alcalde-Villar26, Antonio Juan Mas27, Eugenio De Miguel28, Javier Narvaez29, Miguel Ángel gonzalez-Gay30, Noemí Garrido-Puñal13, Paula V. Estrada-Alarcon17 and Ricardo Blanco31, 1Research unit, Spanish Society of Rheumatology, Madrid, Spain, 2Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 3Rheumatology department, La Paz University Hospital, Madrid, Spain, 4Complejo Hospitalario Universitario de La Coruña, Coruña, Spain, 5Hospital Universitario Donostia, Donostia-San Sebasti, Spain, 6Hospital Universitario de León, León, Spain, 7Hospital Universitario 12 de Octubre, Madrid, Spain, 8Hospital Universitari Bellvitge, Hospitalet de Llobregat, Spain, 9Basurto University Hospital, Bilbao, Spain, 10Complejo Hospitalario de Navarra, Pamplona, Spain, 11Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain, 12Hospital Universitario Marqués de Valdecilla, Santander, Spain, 13Hospital Universitario Virgen del Rocío, Sevilla, Spain, 14Hospital Universitario de la Princesa, Madrid, Spain, 15Hospital Sant Pau, Barcelona, Spain, 16Rheumatology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain, 17Hospital de Sant Joan Despí Moisès Broggi. Sant Joan Despí, Barcelona, Spain, 18Hospital Universitari Parc Tauli, Saadell, Spain, 19Hospital Germans Trias i Pujol, Badalona, Spain, 20Hospital Universitari i Politècnic La Fe, Valencia, Spain, 21Hospital del Mar, Barcelona, Spain, 22Hospital Universitario Araba, Vitoria-Gasteiz, Spain, 23Hospital Universitario Lucus Augusti, Lugo, Spain, 24Hospital Universitario de Canarias, La Laguna, Spain, 25Rheumatology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain, 26Hospital Universitario Severo Ochoa, Leganés, Spain, 27Rheumatology Department, Hospital Universitario Son Llàtzer, Palma de Mallorca, Spain, 28Hospital Universitario La Paz, Madrid, Spain, 29Division of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 30Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 31Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Epidemiological information on Giant Cell Arteritis (GCA) comes mainly from the Scandinavian countries of northern Europe, which show a higher incidence than the countries…
  • Abstract Number: 0302 • ACR Convergence 2020

    Longitudinal Study of Acute SLE Flare Reveals Dynamic Changes in Multiple Immune Cell Subsets

    Kieran Manion1, Dennisse Bonilla2, Dafna Gladman1, Murray Urowitz3, Zahi Touma4 and Joan Wither2, 1Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 2University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 3University Health Network, University of Toronto, Toronto, ON, Canada, 4University of Toronto, Toronto, ON, Canada

    Background/Purpose: In SLE, periods of relative quiescence are punctuated by flares in disease activity that can lead to extensive tissue damage and morbidity. Existing studies…
  • Abstract Number: 1467 • ACR Convergence 2020

    Effectiveness of the Making It Work™ Program at Improving Presenteeism and Work Cessation in Workers with Inflammatory Arthritis – Results of a Randomized Controlled Trial

    Andre Luquini1, Yufei Zheng2, Hui Xie3, Catherine Backman1, Pamela Rogers3, Alex Kwok3, Astrid Knight3, Monique Gignac4, Dianne Mosher5, Linda Li1, John Esdaile6, Carter Thorne7 and Diane Lacaille1, 1University of British Columbia / Arthritis Research Canada, Richmond, BC, Canada, 2Simon Fraser University / Arthritis Research Canada, Richmond, BC, Canada, 3Arthritis Research Canada, Richmond, BC, Canada, 4Institute for Work & Health / University of Toronto, Toronto, ON, Canada, 5University of Calgary, Calgary, AB, Canada, 6Arthritis Research Canada, Vancouver, BC, Canada, 7Southlake Regional Health Centre, Newmarket, ON, Canada

    Background/Purpose: Arthritis often leads to presenteeism (decreased at-work productivity) and permanent work disability, the worst occupational outcome of a disease, leading to reduced quality of…
  • Abstract Number: 0307 • ACR Convergence 2020

    Longitudinal Analysis of the Patient Pathways to Diagnosis of Psoriatic Arthritis

    Alexis Ogdie1, Martin Rozycki2, Theresa Arndt2, Cheng Shi3, Nina Kim4 and Peter Hur3, 1Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2HVH Precision Analytics, LLC, Wayne, PA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4The University of Texas at Austin; Baylor Scott and White Health, Austin, TX

    Background/Purpose: In developing algorithms within claims databases that may inform how to find patients with psoriatic arthritis (PsA) prior to diagnosis, it is important to…
  • Abstract Number: 1471 • ACR Convergence 2020

    Healthy Lifestyle and Risk of Rheumatoid Arthritis in Women: A Prospective Cohort Study

    Jill Hahn1, May Choi2, Susan Malspeis3, Emma Stevens4, Elizabeth Karlson4, Kazuki Yoshida5, Laura Kubzansky6, Jeffrey Sparks7 and Karen Costenbader8, 1Brigham and Womens' Hospital, Newton, MA, 2Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 3Brigham and Women's Hospital, Boston, 4Brigham and Women's Hospital, Boston, MA, 5Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 6Harvard T.H. Chan School of Public Health, Boston, MA, 7Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 8Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Many potentially modifiable biobehavioral factors have been associated with the risk of developing rheumatoid arthritis (RA), but the benefit of adopting an overall healthy…
  • Abstract Number: 0542 • ACR Convergence 2020

    Examining the Long-Term and Short-Term Day-To-Day Pain Variability in Inflammatory and Non-Inflammatory Rheumatic and Musculoskeletal Diseases Using Multilevel and Markov Transition Models: Cloudy with a Chance of Pain, a National U.K. Smartphone Study

    Huai Leng Pisaniello1, Mark Lunt2, John McBeth3 and William Dixon2, 1University of Adelaide, Kidman Park, South Australia, Australia, 2Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom, 3University of Manchester, Manchester, United Kingdom

    Background/Purpose: Chronic pain is common in rheumatic and musculoskeletal diseases (RMDs), yet the patterns and the extent of variability over time are poorly understood. Real-time…
  • Abstract Number: 1493 • ACR Convergence 2020

    Distinct Patient-level Patterns of Response to Methotrexate in Juvenile Idiopathic Arthritis

    Stephanie Shoop-Worrall1, Kimme Hyrich2, Lucy Wedderburn3, Wendy Thomson4 and Nophar Geifman5, 1Centre for Health Informatics, Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, United Kingdom, 2Centre for Epidemiology Versus Arthritis, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 3UCL, UCLH, GOS Institute of Child Health, London, United Kingdom, 4Centre for Genetics and Genomics Versus Arthritis, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 5Centre for Health Informatics, The University of Manchester, Manchester

    Background/Purpose: Treatment response in JIA is often viewed as a binary outcome: response or non-response, usually assessed using composite, multidimensional measures, such as the juvenile…
  • Abstract Number: 0672 • ACR Convergence 2020

    Prospective Study of the Patterns of Joint Involvement for Sequential Gout Flares

    Natalie McCormick1, Chio Yokose1, Clara Chen2, Tuhina Neogi3, David Hunter4, Hyon Choi5 and Yuqing Zhang6, 1Massachusetts General Hospital, Boston, MA, 2Boston University School of Public Health, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Institute of Bone and Joint Research, University of Sydney, St Leonards, New South Wales, Australia, 5Massachusetts General Hospital, Department of Medicine, Division of Rheumatology, Lexington, MA, 6Massachusetts General Hospital, Harvard Medical School, Boston

    Background/Purpose: Cross-sectional radiologic evidence suggests monosodium urate crystal deposition among gout patients is a symmetrical phenomenon,1 but no study has examined the longitudinal patterns in…
  • Abstract Number: 1512 • ACR Convergence 2020

    Trajectory Analysis of Repeat Renal Biopsies Identified Previous Endocapillary Proliferation as Predictor of Damage and End Stage Renal Disease in Pure Membranous Lupus Nephritis

    Andrea Fava1, Avi Rosenberg2, Serena Bagnasco2, Paride Fenaroli2, Jessica Li1, Jose Monroy-Trujillo2, Derek Fine2 and Michelle Petri3, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University, Baltimore, 3Johns Hopkins University School of Medicine, Baltimore

    Background/Purpose: . Pure membranous (class V) lupus nephritis is considered a less aggressive phenotype, but renal fibrosis and chronic kidney disease may develop. Whether this…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology